Speaker
Dr. Lixia Yao, CEO of Polygon Health Analytics, Adjunct Associate Professor in the Department of Health Services Administration and Policy at Temple University, Fellow of the American Medical Informatics Association (FAMIA)
Title
Statistics Seminar Series
Subtitle
Decoding the Mysteries of Health Economics and Outcomes Research and Real-World Data: An Industry Insider's View
Physical Location
Virtual on Webex, Link TBA
Abstract: In this talk, we will explore the vital role of Health Economics and Outcomes Research (HEOR) in shaping healthcare decision-making, emphasizing its importance in evaluating both clinical and economic outcomes. We will then turn to Real-World Data (RWD) and Real-World Evidence (RWE), discussing their differences from traditional clinical data and their growing importance in the pharmaceutical product lifecycle—from drug development to post-market surveillance. Through real-world case studies, we will illustrate the transformative impact of RWD on healthcare innovation. Finally, we will highlight the expanding career opportunities in RWD, offering guidance for individuals interested in pursuing this dynamic and evolving field.
About the Speaker
Dr. Lixia Yao is the founder and CEO of Polygon Health Analytics LLC, which specializes in developing high-quality real-world data (RWD) and real-world evidence (RWE) in disease areas with pressing unmet medical needs.
With a PhD in Biomedical Informatics from Columbia University, Dr. Yao previously worked as the director of Real-world Data Analytics & Innovation at Merck and an Associate Professor in Biomedical Informatics at Mayo Clinic. She has cultivated a deep understanding of RWD and authored 70 peer-reviewed articles on prestigious journals such as Nature Biotechnology, Genome Research, and Drug Discovery Today with a H-index of 21.
Dr. Yao received the Career Development Award in Biomedical Informatics from the National Library of Medicine (2016-2019). She is also a Fellow of the American Medical Informatics Association (FAMIA) and served as the Chair of the AMIA KDDM working group (2020-2022). Currently, she holds the additional roles of Member Engagement Co-Chair for the Oncology Special Interest Group at the Professional Society for Health Economics and Outcomes Research (ISPOR), SAPA Executive Council (EC), and Adjunct Associate Professor in the Department of Health Services Administration and Policy at Temple University.